VRDN logo

Viridian Therapeutics, Inc. (VRDN)

Profile

Full Name

Viridian Therapeutics, Inc.

Ticker

NASDAQ: VRDN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 18, 2014

Indexes

Not included

Website

https://www.viridiantherapeutics.com

Employees

143

Key Details

Price

$22.55(-2.59%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$302.00K(-3.82% YoY)

Annual EPS

-$3.07(42.16% YoY)

PE Ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $22.55
    VRDN price is $22.55

    30-Day Relative Volume

    0.96
    VRDN 30-day relative volume is 0.96

    Price Performance

    Price 1-Day Change

    -2.59%
    VRDN price is down -2.59% today

    Price YTD Change

    +17.63%
    VRDN price is up +17.63% since January 1st

    Price 1-Year Change

    -1.27%
    VRDN price is down -1.27% year-on-year

    Price 3-Year Change

    +14.64%
    VRDN price is up +14.64% over the past 3 years

    Price Range

    Price All-Time High

    $2247.75
    VRDN price is currently -99.00% below its historical high of $2247.75

    Price 3-Year Low

    $9.90
    VRDN price is currently +127.78% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $1.84B
    VRDN market cap is $1.84 billion

    Market Cap 3-Year Change

    +132.63%
    VRDN market cap is up +132.63% over the past 3 years

    Market Cap All-Time High

    $2.04B
    VRDN market cap is currently -9.58% below its historical high of $2.04 billion

    Market Cap Sector Percentile

    79.3%
    VRDN market cap is higher than 79.3% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.13%
    VRDN shares outstanding is up +3.13% year-on-year

    Shares Outstanding 3-Year Change

    +102.92%
    VRDN shares outstanding is up +102.92% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.08
    VRDN beta is 1.08

    200-day SMA

    $16.85
    VRDN price is currently +33.83% above its 200-day simple moving average

    50-day SMA

    $20.83
    VRDN price is currently +8.26% above its 50-day simple moving average

    14-Day RSI

    53.11
    VRDN 14-day relative strength index is 53.11

    Volume

    0.96
    VRDN 30-day relative volume is 0.96

    ATR

    $1.06
    VRDN average true range is $1.06

    10-day Historical Volatility

    54.34%
    VRDN 10-day historical volatility is 54.34%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $302.00K
    VRDN annual revenue is $302.00 thousand

    Revenue Analysts Estimate

    $15.21M
    VRDN annual revenue is currently -98.01% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -3.82%
    VRDN annual revenue is down -3.82% year-on-year

    Revenue Sector Percentile

    33.42%
    VRDN annual revenue is higher than 33.42% of companies in Healthcare sector

    EPS

    EPS

    -$3.07
    VRDN annual earnings per share is -$3.07

    EPS Analysts Estimate

    -$4.05
    VRDN annual earnings per share is currently +24.16% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +42.16%
    VRDN annual earnings per share is up +42.16% year-on-year

    EPS Sector Percentile

    29.36%
    VRDN annual earnings per share is higher than 29.36% of companies in Healthcare sector

    Profit

    Gross Profit

    -$938.00K
    VRDN annual gross profit is -$938.00 thousand

    Gross Margin

    -310.60%
    VRDN annual gross profit margin is -310.60%

    Operating Profit

    -$299.04M
    VRDN annual operating income is -$299.04 million

    Operating Margin

    -99.02K%
    VRDN annual operating profit margin is -99.02 thousand%

    Net Income

    -$208.56M
    VRDN annual net profit is -$208.56 million

    Net Margin

    -89.39K%
    VRDN annual net profit margin is -89.39 thousand%

    Expenses

    Total Expenses

    $299.34M
    VRDN annual total expenses is $299.34 million

    Operating Expenses

    $299.34M
    VRDN annual total operating expenses is $299.34 million

    Cost Of Goods Sold

    $1.24M
    VRDN annual cost of goods sold is $1.24 million

    Selling, General & Administrative Expenses

    $61.08M
    VRDN annual SG&A is $61.08 million

    Depreciation & Amortization

    $540.00K
    VRDN annual D&A is $540.00 thousand

    Interest Expense

    $3.05M
    VRDN annual interest expense is $3.05 million

    Income Tax

    $0.00
    VRDN annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$266.90M
    VRDN annual earnings before interest & taxes is -$266.90 million

    EBITDA

    -$266.36M
    VRDN annual EBITDA is -$266.36 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $742.40M
    VRDN annual total assets is $742.40 million

    Non Current Assets

    $3.94M
    VRDN annual long term assets is $3.94 million

    Current Assets

    $738.46M
    VRDN annual total current assets is $738.46 million

    Cash and Cash Equivalents

    $99.59M
    VRDN annual cash & cash equivalents is $99.59 million

    Accounts Receivable

    $0.00
    VRDN annual accounts receivable is $0.00

    Inventory

    $0.00
    VRDN annual inventory is $0.00

    Liabilities

    Total Liabilities

    $70.76M
    VRDN annual total liabilities is $70.76 million

    Long Term Liabilities

    $22.89M
    VRDN annual total long term liabilities is $22.89 million

    Current Liabilities

    $47.87M
    VRDN annual current liabilities is $47.87 million

    Accounts Payable

    $2.14M
    VRDN annual accounts payable is $2.14 million

    Debt

    Total Debt

    $23.09M
    VRDN annual total debt is $23.09 million

    Total Debt 1-Year Change

    +4.75%
    VRDN annual total debt is up +4.75% year-on-year

    Long Term Debt

    $22.58M
    VRDN annual long term debt is $22.58 million

    Short Term Debt

    $513.00K
    VRDN annual short term debt is $513.00 thousand

    Equity & Capital

    Shareholders Equity

    $671.64M
    VRDN annual stockholders equity is $671.64 million

    Book Value

    $482.75M
    VRDN annual book value is $482.75 million

    Retained Earnings

    -$995.86M
    VRDN annual retained earnings is -$995.86 million

    Working Capital

    $690.59M
    VRDN annual working capital is $690.59 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$232.32M
    VRDN annual cash from operations is -$232.32 million

    Cash From Operations 1-Year Change

    -26.14%
    VRDN annual cash from operations is down -26.14% year-on-year

    Cash From Investing

    -$228.65M
    VRDN annual cash from investing is -$228.65 million

    Cash From Investing 1-Year Change

    -142.6%
    VRDN annual cash from investing is down -142.6% year-on-year

    Cash From Financing

    $457.74M
    VRDN annual cash from financing is $457.74 million

    Cash From Financing 1-Year Change

    +102.83%
    VRDN annual cash from financing is up +102.83% year-on-year

    CAPEX

    CAPEX

    $511.00K
    VRDN annual capital expenditures is $511.00 thousand

    CAPEX 1-Year Change

    -43.1%
    VRDN annual capital expenditures is down -43.1% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$232.83M
    VRDN annual free cash flow is -$232.83 million

    Free Cash Flow 1-Year Change

    -25.81%
    VRDN annual free cash flow is down -25.81% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -310.60%
    VRDN annual gross profit margin is -310.60%

    Operating Margin

    -99.02K%
    VRDN annual operating profit margin is -99.02 thousand%

    Net Margin

    -89.39K%
    VRDN annual net profit margin is -89.39 thousand%

    ROA & ROE

    ROA

    -33.83%
    VRDN annual return on assets is -33.83%

    ROE

    -37.45%
    VRDN annual return on equity is -37.45%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    VRDN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    VRDN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    5.64
    VRDN price to book ratio is 5.64

    PB Ratio Sector Percentile

    79.26%
    VRDN price to book ratio is higher than 79.26% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    6037.66
    VRDN price to sales ratio is 6037.66

    PS Ratio Sector Percentile

    99.51%
    VRDN price to sales ratio is higher than 99.51% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.30B
    VRDN enterprise value is $1.30 billion

    Enterprise Value Sector Percentile

    75.76%
    VRDN enterprise value is higher than 75.76% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.51
    VRDN EV/EBITDA is -3.51

    EV/EBITDA Sector Percentile

    29.61%
    VRDN EV/EBITDA is higher than 29.61% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    15.43
    VRDN annual current ratio is 15.43

    Quick Ratio

    15.43
    VRDN annual quick ratio is 15.43

    Leverage

    Debt To Equity

    0.03
    VRDN annual debt to equity ratio is 0.03

    Interest Coverage Ratio

    -87.62
    VRDN annual interest coverage ratio is -87.62

    Risk & Stability

    F-Score

    3
    VRDN piotroski f-score is 3

    Altman Z-Score

    13.67
    VRDN altman z-score is 13.67

    Analyst ratings

    Recent major analysts updates

    Oct 21, 25 Oppenheimer
    Outperform
    Aug 7, 25 Wells Fargo
    Equal-Weight
    Aug 7, 25 RBC Capital
    Outperform
    Aug 7, 25 Oppenheimer
    Outperform
    Aug 7, 25 Goldman Sachs
    Buy
    Aug 6, 25 Needham
    Buy
    May 20, 25 Needham
    Buy
    May 7, 25 RBC Capital
    Outperform
    May 7, 25 Needham
    Buy
    May 7, 25 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with VRDN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Viridian Therapeutics, Inc.?
    • Does Viridian Therapeutics, Inc. pay dividends?
    • What sector is Viridian Therapeutics, Inc. in?
    • What industry is Viridian Therapeutics, Inc. in?
    • What country is Viridian Therapeutics, Inc. based in?
    • When did Viridian Therapeutics, Inc. go public?
    • Is Viridian Therapeutics, Inc. in the S&P 500?
    • Is Viridian Therapeutics, Inc. in the NASDAQ 100?
    • Is Viridian Therapeutics, Inc. in the Dow Jones?
    • When was Viridian Therapeutics, Inc.'s last earnings report?
    • When does Viridian Therapeutics, Inc. report earnings?

    What is the ticker symbol for Viridian Therapeutics, Inc.?

    The ticker symbol for Viridian Therapeutics, Inc. is NASDAQ:VRDN

    Does Viridian Therapeutics, Inc. pay dividends?

    No, Viridian Therapeutics, Inc. does not pay dividends

    What sector is Viridian Therapeutics, Inc. in?

    Viridian Therapeutics, Inc. is in the Healthcare sector

    What industry is Viridian Therapeutics, Inc. in?

    Viridian Therapeutics, Inc. is in the Biotechnology industry

    What country is Viridian Therapeutics, Inc. based in?

    Viridian Therapeutics, Inc. is headquartered in United States

    When did Viridian Therapeutics, Inc. go public?

    Viridian Therapeutics, Inc.'s initial public offering (IPO) was on June 18, 2014

    Is Viridian Therapeutics, Inc. in the S&P 500?

    No, Viridian Therapeutics, Inc. is not included in the S&P 500 index

    Is Viridian Therapeutics, Inc. in the NASDAQ 100?

    No, Viridian Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Viridian Therapeutics, Inc. in the Dow Jones?

    No, Viridian Therapeutics, Inc. is not included in the Dow Jones index

    When was Viridian Therapeutics, Inc.'s last earnings report?

    Viridian Therapeutics, Inc.'s most recent earnings report was on May 7, 2025

    When does Viridian Therapeutics, Inc. report earnings?

    The next expected earnings date for Viridian Therapeutics, Inc. is November 10, 2025
    On this page